Research – Page 9 – Phelan-McDermid Syndrome Foundation

Comorbidities of Epilepsy in Persons with PMS: Results from the Rare Epilepsy Network

By Geraldine BlissPMSF Board Member and mom to Charles In 2014 PMS families whose children have epilepsy were invited to participate…

Piloting Treatment with IGF-1 in Phelan-McDermid Syndrome

By Geraldine Bliss, Board Member and Research Liaison Since 2012, the Seaver Autism Center at the Icahn School of Medicine at Mt. Sinai…

Research Experience Survey Results

By Diane Linnehan, Program Director The results are in! One of the primary strategic objectives of the Foundation Family Support is to characterize the…

First SHANK3-deficient primate model

By Geraldine Bliss, Director, Phelan-McDermid Syndrome Foundation July 28, 2017 Over the last several years there have been many important…

Stanford researcher finds high prevalence of sleep issues in those with PMS

Ninety percent of individuals with Phelan-McDermid Syndrome have sleep disturbances, according to the results of a Stanford University study. However, only 22…

New seizure registry now available for Phelan-McDermid Syndrome families

Twenty-one rare epilepsy organizations have joined forces with the Epilepsy Foundation, Research Triangle Institute, Columbia University and New York University to…

Lithium As a Rescue Therapy…

Lithium as a rescue therapy for regression and catatonia features in two SHANK3 patients with autism spectrum disorder: Case Report Read…

Researchers unravel a link between a genetic mutation and autistic behaviors – and then find a way to undo it.

Scientists at the University at Buffalo have identified the mechanisms behind a genetic mutation that produces certain autistic behaviors in mice,…

Oxytocin sails into trials for Phelan-McDermid syndrome

The hormone oxytocin is proceeding into clinical trials for people with Phelan-McDermid syndrome, researchers revealed yesterday at the 2015 International Meeting for…